Blaise A Coleman

BioSpecifics Technologies Corp. engages in the development of an injectable collagenase clostridium histolyticum for multiple indications. It sells its products under the brand XIAFLEX. The company was founded in 1990 and is headquartered in Lynbrook, NY.

Auxilium Pharmaceuticals LLC develops and markets pharmaceutical products. It specializes in men's healthcare area and has product portfolio and pipeline in orthopedics, dermatology and other therapeutic areas. The firm products include edex, Osbon, ErecAid, STENDRA, TESTOPEL, XIAFLEX and Testim. The company was founded by Gerri A. Henwood and Jane Holmes Hollingsworth in 1999 and is headquartered in Chesterbrook, PA.

Endo International Plc operates as a pharmaceutical company, which engages in the development, manufacture, and distribution of branded and generic pharmaceutical products. It operates through the following segments: Branded Pharmaceuticals, Sterile Injectables, Generic Pharmaceuticals and International Pharmaceuticals. The Branded Pharmaceuticals segment conducts certain operations in the U.S. through leased and owned manufacturing properties in Pennsylvania, New York and New Jersey, as well as certain administrative and R&D functions through leased properties in Pennsylvania. The Sterile Injectables segment includes manufacturing, quality assurance, research and development, and administration functions. The Generic Pharmaceuticals segment is composed of manufacturing, distribution, quality assurance and administration functions, as well as certain research and development functions. The International Pharmaceuticals segment’s operations are currently conducted through Paladin’s leased headquarters in Montreal, Canada. The company was founded in 1997 and is headquartered Dublin, Ireland.

AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden.

Par Pharmaceutical, Inc. manufactures and markets generic drugs and pharmaceuticals products. It produces drugs for hypertension, inflammation, depression and pain. The firm distributes its products in the semi-solid form of a cream. The company was founded in 1978 and is headquartered in Chestnut Ridge, NY.

Founded in 1983, Qualitest provides affordable, high-quality generic pharmaceuticals. Featuring a current portfolio exceeding 600 products, the company has grown significantly since its inception and is now ranked in the top ten among all suppliers of generics, based on total prescriptions filled. Privately held, Qualitest has its headquarters and distribution facilities in Huntsville, Alabama, with a workforce of over 600 employees.

Par Sterile Products LLC engages in the development, manufacturing, and distribution of generic pharmaceuticals. Its products include adrenalin injection, adrenalin chloride solution, aplisol, argatroban injection, brevital sodium, buprenorphine HCL injection, CIII, colistimethate for injection, USP, coly-mycin m, dantrium IV, dantrium capsules, delestrogen, dexmedetomidine HCI, injection, ethacrynate sodium for injection, USP, fluphenazine decanoate injection, USP, ketalar, pitocin, tigan, triostat, vasostrict, and zoledronic acid injection. The company was founded in 2007 and is headquartered in Chestnut Ridge, NY.

Part of AstraZeneca PLC, AstraZeneca US Investments Ltd. functions as an investment holding British company. The company is based in Cambridge, UK and was founded in 2002.

Par Pharmaceutical Holdings, Inc. operates as a holding company that engages in the development, license, manufacture, market, and distribution of generic drugs. The company was founded on July 12, 2012 and is headquartered in New York.